Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer

Carcinogenesis

Volumn 29, Issue 1, 2008, Pages 84-92

  Yue, Wen ^a   Sun, Quanhong ^a   Dacic, Sanja ^a   Landreneau, Rodney J ^a   Siegfried, Jill M ^a   Yu, Jian ^a   Zhang, Lin ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; DICKKOPF 3 PROTEIN; GLYCOPROTEIN; MYC PROTEIN; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; LUNG TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

BETA CATENIN; DOWN-REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS;

EID: 38849145619     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm267     Document Type: Article

References (53)

1. Vogelstein,B. et al. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799.
2. Clevers,H. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
3. Polakis,P. (2007) The many ways of Wnt in cancer. Curr Opin. Genet. Dev, 17, 45-51.
4. Bafico,A. et al. (2004) An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell, 6 497-506.
5. Morin,P.J. et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275, 1787-1790.
6. Sparks,A.B. et al. (1998) Mutational analysis of the APC/b-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
7. Korinek,V. et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science, 275, 1784-1787.
8. He,T.C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
9. Tetsu,O. et al. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
10. Minna,J.D. et al. (2002) Focus on lung cancer. Cancer Cell, 1, 49-52.
11. Winn,R.A. et al. (2002) Gamma-catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene, 21, 7497-7506.
12. Lim,J.H. et al. (2006) Human arrest defective 1 acetylates and activates beta-catenin promoting lung cancer cell proliferation. Cancer Res., 66, 10677-10682.
13. Uematsu,K. et al. (2003) Activation of the Wnt pathway in non small cell lung cancer: Evidence of dishevelled overexpression. Oncogene, 22, 7218-7221.
14. You,L. et al. (2004) Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene, 23, 6170-6174.
15. Shigemitsu,K. et al. (2001) Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene, 20, 4249-4257.
16. Ohgaki,H. et al. (2004) APC mutations are infrequent but present in human lung cancer. Cancer Lett., 207, 197-203.
17. Sunaga,N. et al. (2001) Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer, 30, 316-321.
18. Krupnik,V.E. et al. (1999) Functional and structural diversity of the human Dickkopf gene family. Gene, 238, 301-313.
19. Niehrs,C. (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene, 25, 7469-7481.
20. Tsuji,T. et al. (2000) A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem. Biophys. Res. Commun., 268, 20-24.
21. Hsieh,S.Y. et al. (2004) Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene, 23, 9183-9189.
22. Kurose,K. et al. (2004) Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J. Urol., 171, 1314-1318.
23. Roman-Gomez,J. et al. (2004) Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia. Br J. Cancer, 91, 707-713.
24. Lodygin,D. et al. (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res., 65, 4218-4227.
25. Kuphal,S. et al. (2006) Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene, 25, 5027-5036.
26. Kobayashi,K. et al. (2002) Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene, 282, 151-158.
27. Aguilera,O. et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene, 25, 4116-4121.
28. Urakami,S. et al. (2006) Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin. Cancer Res., 12, 2109-2116.
29. Sato,H. et al. (2007) Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis, 28, 2459-2466.
30. Chim,C.S. et al. (2007) Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia, 21, 2527-2536.
31. Glinka,A. et al. (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature, 391 357-362.
32. Mao,B. et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature, 411, 321-325.
33. Hoang,B.H. et al. (2004) Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res., 64, 2734-2739.
34. Caricasole,A. et al. (2003) Functional characterization of WNT7A signaling in PC 12 cells: Interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. J. Biol. Chem., 278, 37024-37031.
35. Ming,L. et al. (2006) PUMA dissociates Bax and BCL-XL to induce apoptosis in colon cancer cells. J. Biol. Chem., 281, 16034-16042.
36. Herman,J.G. et al. (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
37. Yue,W. et al. (2007) Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin. Cancer Res. 13, 4336-4344.
38. Wang,P. et al. (2007) The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc. Natl Acad Sci. USA, 104, 4054-4059.
39. Kohli,M. et al. (2004) SMAC/Diablo-dependent apoptosis induced by non-steroidal antiinflammatory drugs (NSAIDs) in colon cancer cells. Proc. Natl Acad Sci. USA, 101, 16897-16902.
40. Behmens,J. et al. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature, 382, 638-642.
41. Yu,J. et al. (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell, 7, 673-682.
42. Boon,K. et al. (2002) An anatomy of normal and malignant gene expression. Proc. Natl Acad. Sci. USA, 99, 11287-11292.
43. Nacht,M. et al. (2001) Molecular characteristics of non-small cell lung cancer. Proc. Natl Acad. Sci. USA, 98, 15203-15208.
44. Esteller,M. et al. (2001) A gene hypermethylation profile of human cancer. Cancer Res., 61, 3225-3229.
45. Aberle,H. et al. (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
46. Jones,P.A. et al. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
47. Tsuji,T. et al. (2001) Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem. Biophys. Res. Commun., 289, 257-263.
48. Bepler,G. et al. (2002) Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J. Clin. Oncol., 20, 1353-1360.
49. Dammann,R. et al. (2005) CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur J. Cancer, 41 1223-1236.
50. Morin,P.J. et al. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA, 93, 7950-7954.
51. He,T.C. et al. (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345.
52. Barrantes Idel,B. et al. (2006) Generation and characterization of dick-kopf3 mutant mice. Mol. Cell. Biol., 26, 2317-2326.
53. Hastie,N.D. et al. (1976) The expression of three abundance classes of messenger RNA in mouse tissues. Cell, 9, 761-774.